While the approval is hailed as a significant milestone for Neuralink, critics argue that there are several potential risks and ethical implications associated with the technology

Elon Musk’s Brain-Computer Company “Neuralink” Receives FDA Approval to Launch Human Clinical Trial

By News on the Net -- The Gateway Pundit——Bio and Archives--May 26, 2023

Elon Musk’s brain-implant company Neuralink announced on Thursday that it has been granted official approval from the U.S. Food and Drug Administration (FDA) to launch its first-in-human clinical study.

“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!” Neuralink wrote on Twitter. ---More...

View Comments

News on the Net——Bio and Archives

News from around the world